Neurotech company info

What does Neurotech do?
Neurotech International (ASX:NTI) is a biopharmaceutical company focused on the development and commercialisation of neurological solutions that improve quality of life. The company's lead drug candidate, NTI164, is currently in Phase II clinical trials for the treatment of moderate autism spectrum disorder in children. NTI is also commercialising Mente, the world's first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity. NTI's operations are centred around its two key projects: the NTI164 clinical trials and the commercialisation of Mente.
Neurotech company media
Company Snapshot

Is Neurotech a public or private company?

key
Ownership
Public

How many people does Neurotech employ?

people
Employees
10

What sector is Neurotech in?

pie chart
Sector
Health Care

Where is the head office for Neurotech?

location pin
Head Office
Nedlands, Western Australia

What year was Neurotech founded?

founded flag
Year Founded
2016
What does Neurotech specialise in?
/Health /Pharmaceutical /Biotech /Cannabis /Biopharmaceutical /Neurological conditions /Autism

What are the products and/or services of Neurotech?

Overview of Neurotech offerings
NTI164: a potent blend of CBDA and assorted minor cannabinoids, including less than 0.3% THC, offers a distinct mechanism from CBD, actively targeting inflammatory pathways and inhibiting cytokine activity.
Mente: Mente uses personalised audio feedback and earphones to gently guide the brain into a more relaxed state. Based on autism research and a successful clinical trial, Mente is a soft, easy to use and portable headband that was developed to help those on the autism spectrum improve their ability to relax.

Who is in the executive team of Neurotech?

Neurotech leadership team
  • Dr. Alexandra  Andrews
    Dr. Alexandra Andrews
    Chief Operating Officer
  • Mr. Gerald  Quigley
    Mr. Gerald Quigley
    Director of Public Relations & Director
  • Dr. Thomas  Duthy M.B.A., Ph.D.
    Dr. Thomas Duthy M.B.A., Ph.D.
    Executive Director
  • Dr. Emanuela  Russo
    Dr. Emanuela Russo
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Mr. Peter James Lawrence Griffiths B.Sc.
    Mr. Peter James Lawrence Griffiths B.Sc.
    Chief Executive Officer of AAT Research Ltd
  • Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG
    Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG
    Company Secretary